Associate Clinical Professor of Radiology, University Miami School of Medicine
Radiation Oncology
Dr. Michael J. Katin, MD
|
|
Give Review
Michael Katin works in the field of Radiation Oncology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Gulfshore Life Magazine: Top Doctors". Michael Katin is a published MD. He published 33 publications, including: 'Small-cell lung carcinoma: an analysis of 194 consecutive patients.' Michael Katin is registered with Medicare.
Publications
- Neoadjuvant hormonal therapy use and the risk of death in men with prostate Cancer treated with brachytherapy who have no or at least a single risk factor for coronary...
- Diabetes mellitus, race and the odds of high grade prostate Cancer in men treated with radiation therapy.
- Race and Survival Following Brachytherapy-based Treatment for Men With Localized or Locally Advanced AdenoCarcinoma of the Prostate.
- Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer.
- Cholinergic control of male mating behavior in hamsters: Effects of central oxotremorine treatment.
- Coronary artery revascularization and the risk of death in men with prostate Cancer.
- Risk of death from prostate Cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.
- Risk of all-cause and prostate Cancer-specific mortality after brachytherapy in men with small prostate size.
- Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation.
- Androgen-suppression therapy for prostate Cancer and the risk of death in men with a history of myocardial infarction or stroke.
- Prostate Cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate Cancer.
- Predictors of prostate Cancer-specific mortality in elderly men with intermediate-risk prostate Cancer treated with brachytherapy with or without external beam radiati...
- The use of supplemental external beam radiotherapy in men with low-risk prostate Cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Socie...
- Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate Cancer treated with radiotherapy.
- Mortality in men with localized prostate Cancer treated with brachytherapy with or without neoadjuvant hormone therapy.
- Risk of death from prostate Cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
- Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-HDRT): technique and outcome.
- Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair Analysis.
- Effective palliative radiation therapy in advanced and recurrent ovarian Carcinoma.
- Edelfosine, apoptosis, MDR and Na+/H+ exchanger: induction mechanisms and treatment implications.
- Small-cell lung carcinoma: an Analysis of 194 consecutive patients.
- Small Cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy.
- Low doses of prophylactic cranial irradiation effective in limited stage small Cell carcinoma of the lung.
- Radiation and chemotherapy. Treatment of localized pancreatic Carcinoma.
- Local control in medically inoperable lung Cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication.
- Prevention of heterotopic bone formation with low dose radiation therapy.
- Radiation therapy in the management of medically inoperable Carcinoma of the lung: results and implications for future treatment strategies.
- Late cardiac effects of therapeutic Mediastinal irradiation. Assessment by echocardiography and radionuclide angiography.
- Hierarchical organization, integrations in biology and Cancer, balance loss, and a question on modernism.
- Surgical repair of esophagobronchial fistula following successful treatment of Hodgkin''s Disease.
- Reasons for familial aggregation in Hodgkin''s Disease.
- Resorcinol-induced hypothydroidism in a patient on chronic hemodialysis.
Schools
University Of Pennsylvania School Of Medicine
Lankenau Hospital
Massachusetts General Hospital
Roswell Park Meml Institute
National Institute Of Health
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Geriatric Medicine
- Hematology
- Medical Oncology
- Oncology
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Gulfshore Life Magazine: Top Doctors
Education
-
Massachusetts General Hospital -
Lankenau Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Lee Memorial Hospital
Drug Facts
| NPI NUMBER | 1811994999 | |
| NPPES Provider LastName | KATIN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 339085122 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 247.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 6.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811994999 |
| Last Name Of The Provider | KATIN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. James H. Rubenstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan L. Brown Jr., MD |
|
|
Dr. Keith L. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enrique R. Luks, MD
This Doctor is OpenDoctor Recommended.
|